GENEVA, Dec. 9 -- ZEALAND PHARMA A/S (Sydmarken 112860 Soborg) filed a patent application (PCT/EP2025/065062) for "DAPIGLUTIDE FOR USE IN TREATING A SUB-GROUP OF SUBJECTS" on May 30, 2025. With publication no. WO/2025/248124, the details related to the patent application was published on Dec 04, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MATHIESEN, Jesper Mosolff (c/o Zealand Pharma A/SSydmarken 112860 Soborg), ELSTER, Lisbeth (c/o Zealand Pharma A/SSydmarken 112860 Soborg)
Abstract: The present invention relates to use of a GLP-1R/GLP-2R dual agonist, namely dapiglutide, for treatment...